FDA Drug Shortage Assistance Award
Fresenius Kabi received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration (FDA) on October 23rd, 2018.
The FDA recognized the role Fresenius Kabi played in helping mitigate a shortage of IV saline, specifically Sodium Chloride Injection USP, 0.9% in bags. The shortage was caused last year by supply disruptions at manufacturers affected by Hurricane Maria. The hurricane devastated Puerto Rico, where many companies produce medicines for U.S. hospitals.